Pictet Asset Management (UK)’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $4.62M | Sell |
76,191
-88,150
| -54% | -$5.35M | 0.01% | 860 |
|
|
2021
Q1 | $11.5M | Sell |
164,341
-62,687
| -28% | -$4.39M | 0.01% | 623 |
|
|
2020
Q4 | $13.6M | Sell |
227,028
-12,500
| -5% | -$748K | 0.02% | 555 |
|
|
2020
Q3 | $14.4M | Sell |
239,528
-22,422
| -9% | -$1.35M | 0.02% | 478 |
|
|
2020
Q2 | $13.7M | Sell |
261,950
-24,800
| -9% | -$1.3M | 0.02% | 462 |
|
|
2020
Q1 | $9.62M | Buy |
286,750
+25,100
| +10% | +$842K | 0.02% | 483 |
|
|
2019
Q4 | $11.9M | Sell |
261,650
-15,300
| -6% | -$693K | 0.02% | 525 |
|
|
2019
Q3 | $10.5M | Buy |
276,950
+25,200
| +10% | +$959K | 0.02% | 509 |
|
|
2019
Q2 | $10.9M | Buy |
251,750
+59,750
| +31% | +$2.6M | 0.02% | 499 |
|
|
2019
Q1 | $7.31M | Buy |
192,000
+64,400
| +50% | +$2.45M | 0.02% | 589 |
|
|
2018
Q4 | $5.49K | Buy |
127,600
+35,200
| +38% | +$1.51K | 0.01% | 635 |
|
|
2018
Q3 | $4.54M | Sell |
92,400
-9,800
| -10% | -$482K | 0.01% | 746 |
|
|
2018
Q2 | $3.28M | Buy |
102,200
+5,985
| +6% | +$192K | 0.01% | 746 |
|
|
2018
Q1 | $3M | Buy |
96,215
+64,552
| +204% | +$2.01M | 0.01% | 752 |
|
|
2017
Q4 | $1.45M | Sell |
31,663
-19,703
| -38% | -$899K | ﹤0.01% | 817 |
|
|
2017
Q3 | $1.93M | Buy |
+51,366
| New | +$1.93M | 0.01% | 791 |
|